Teleflex Incorporated (TFX) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, ma...
Teleflex Incorporated's revenue decreased 34.6% year over year, from $3.05B to $1.99B.
Net income decreased 1399.8% over the same period, from $69.7M to $-905.6M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 7% in total.
Total debt increased by 59.5% to $2.64B.
The debt-to-equity ratio stands at 0.85, indicating a moderate leverage profile.
Operating cash flow declined 84.9% to $96.7M.
Teleflex Incorporated maintains a negative net profit margin of -45.4%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $764.4M+2.0% | $111.0M | $430.2M | $149.3M | $231.1M | $7.49B | $1.76B | $4.48B |
| Q4 FY2024 | $795.4M+4.1% | $-136.7M | $439.9M | $-110.4M | $202.6M | $7.10B | $1.66B | $4.28B |
| Q1 FY2025 | $700.7M-11.9% | $95.0M | $389.4M | $77.2M | $73.3M | $7.16B | $1.91B | $4.10B |
| Q2 FY2025 | $780.9M+11.4% | $122.6M | $431.1M | $101.8M | $7.8M | $7.38B | $1.90B | $4.24B |
| Q3 FY2025 | $913.0M+16.9% | $-408.9M | $451.6M | $113.3M | $107.8M | $7.87B | $2.67B | $3.82B |
| Q4 FY2025 | $-401.9M-144.0% | $-714.3M | $-151.4M | $-860.0K | $-92.3M | $6.95B | $2.64B | $3.12B |
| Q1 FY2026 | $548.3M+236.4% | $-8.2M | $307.4M | $45.1M | $46.7M | $6.78B | $2.74B | $3.08B |
| Q2 FY2026 | $570.3M+4.0% | $99.7M | $331.7M | $47.9M | $91.9M | $6.79B | $2.94B | $2.90B |
Balance Sheet Summary (Q2 FY2026)
Teleflex Incorporated (TFX) Financial Statements & Revenue History
Teleflex Incorporated (TFX) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry trading at $130.43 with a market capitalization of $6. This page provides 42 historical financial statements for Teleflex Incorporated, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Teleflex Incorporated reported revenue of $2.0 billion, a 34.6% decline from the prior year. The net profit margin of -45.4% indicates the company is currently unprofitable. The debt-to-equity ratio of 0.85 reflects moderate leverage.
TFX Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Teleflex Incorporated's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether TFX is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track TFX's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Teleflex Incorporated converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of TFX's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use TFX Financial Data
Investors use Teleflex Incorporated's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare TFX's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how TFX's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View TFX's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Teleflex Incorporated's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.TFX trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.